Palbociclib and Fulvestrant Act in Synergy to Modulate Central Carbon Metabolism in Breast Cancer Cells

The aims of this study were to determine whether combination chemotherapeutics exhibit a synergistic effect on breast cancer cell metabolism. Palbociclib, is a selective inhibitor of cyclin-dependent kinases 4 and 6, and when patients are treated in combination with fulvestrant, an estrogen receptor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Metabolites
Autors principals: Warth, Benedikt, Palermo, Amelia, Rattray, Nicholas J.W., Lee, Nathan V., Zhu, Zhou, Hoang, Linh T., Cai, Yuping, Mazurek, Anthony, Dann, Stephen, VanArsdale, Todd, Fantin, Valeria R., Shields, David, Siuzdak, Gary, Johnson, Caroline H.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6359333/
https://ncbi.nlm.nih.gov/pubmed/30609717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo9010007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars